{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:50Z","timestamp":1791357290693,"version":"4.3.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0231700","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T20:19:21Z","timestamp":1587500361000},"page":"e0231700","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":104,"title":["Pharmacological treatment of depression: A systematic review comparing clinical practice guideline recommendations"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4375-3729","authenticated-orcid":true,"given":"Franciele Cordeiro","family":"Gabriel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8613-7953","authenticated-orcid":true,"given":"Daniela Oliveira","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9rio","family":"Fr\u00e1guas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nath\u00e1lia Celini","family":"Leite-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Augusto","family":"Mantovani da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"issue":"10009","key":"pone.0231700.ref001","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0140-6736(15)61340-X","article-title":"Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990\u20132013: quantifying the epidemiological transition","volume":"386","author":"CJL Murray","year":"2015","journal-title":"Lancet"},{"key":"pone.0231700.ref002","first-page":"21","volume-title":"Depression and other common mental disorders: global health estimates","author":"World Health Organization","year":"2017"},{"issue":"10128","key":"pone.0231700.ref003","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review","volume":"391","author":"A Cipriani","year":"2018","journal-title":"Lancet"},{"issue":"7354","key":"pone.0231700.ref004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/475027a","article-title":"Grand challenges in global mental health","volume":"475","author":"PY Collins","year":"2011","journal-title":"Nature"},{"key":"pone.0231700.ref005","volume-title":"Clinical practice guidelines we can trust","author":"Institute of Medicine (US)","year":"2011"},{"issue":"6","key":"pone.0231700.ref006","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-139-6-200309160-00013","article-title":"Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization","volume":"139","author":"RN Shiffman","year":"2003","journal-title":"Ann Intern Med"},{"issue":"7182","key":"pone.0231700.ref007","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/bmj.318.7182.527","article-title":"Potential benefits, limitations, and harms of clinical guidelines","volume":"318","author":"SH Woolf","year":"1999","journal-title":"BMJ"},{"key":"pone.0231700.ref008","volume-title":"Appraisal of guidelines for research and evaluation (AGREE) instrument","author":"AGREE Collaboration","year":"2001"},{"issue":"7517","key":"pone.0231700.ref009","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/bmj.331.7517.631","article-title":"Developing clinical guidelines: a challenge to current methods","volume":"331","author":"R Raine","year":"2005","journal-title":"BMJ"},{"issue":"6","key":"pone.0231700.ref010","first-page":"e58","article-title":"The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies","volume":"19","author":"P Alonso-Coello","year":"2010","journal-title":"Qual Saf Health Care"},{"key":"pone.0231700.ref011","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jclinepi.2016.08.005","article-title":"Improvement evident but still necessary in clinical practice guideline quality: a systematic review","volume":"81","author":"JJ Armstrong","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"pone.0231700.ref012","article-title":"Factors associated with high-quality guidelines: a systematic review and appraisal of 421 guidelines for the pharmacological management of chronic diseases in primary care","author":"CGRC Molino","year":"2019","journal-title":"JAMA Intern Med"},{"key":"pone.0231700.ref013","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2018.11.030","article-title":"Systematic reviews of clinical practice guidelines: a methodological guide","volume":"108","author":"A Johnston","year":"2019","journal-title":"J Clin Epidemiol"},{"key":"pone.0231700.ref014","first-page":"828917","article-title":"Clinical practice guidelines in psychiatry: more confusion than clarity? A critical review and recommendation of a unified guideline","volume":"2014","author":"S Saddichha","year":"2014","journal-title":"SRN Psychiatry"},{"issue":"3","key":"pone.0231700.ref015","doi-asserted-by":"crossref","first-page":"e0174831","DOI":"10.1371\/journal.pone.0174831","article-title":"Guideline appraisal with AGREE II: systematic review of the current evidence on how users handle the 2 overall assessments","volume":"12","author":"W Hoffmann-E\u00dfer","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"pone.0231700.ref016","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12913-018-2954-8","article-title":"Guideline appraisal with AGREE II: online survey of the potential influence of AGREE II items on overall assessment of guideline quality and recommendation for use","volume":"18","author":"W Hoffmann-E\u00dfer","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"pone.0231700.ref017","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jclinepi.2017.12.009","article-title":"Systematic review of current guideline appraisals performed with the Appraisal of Guidelines for Research & Evaluation II instrument\u2014a third of AGREE II users apply a cut-off for guideline quality","volume":"95","author":"W Hoffmann-E\u00dfer","year":"2018","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"pone.0231700.ref018","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1542\/peds.2013-2744","article-title":"Pediatric clinical practice guidelines for acute procedural pain: a systematic review","volume":"133","author":"GY Lee","year":"2014","journal-title":"Pediatrics"},{"issue":"5","key":"pone.0231700.ref019","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1533-2500.2012.00602.x","article-title":"Guidelines for neuropathic pain management in patients with cancer: a European survey and comparison","volume":"13","author":"V Piano","year":"2013","journal-title":"Pain Pract"},{"issue":"4","key":"pone.0231700.ref020","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jvs.2015.12.040","article-title":"Quality assessment of peripheral artery disease clinical guidelines","volume":"63","author":"AM Barriocanal","year":"2016","journal-title":"J Vasc Surg"},{"key":"pone.0231700.ref021","volume-title":"Gu\u00eda cl\u00ednica AUGE depresion en personas de 15 a\u00f1os y mas","author":"Chile, Ministerio de Salud (MINSAL)","year":"2013"},{"key":"pone.0231700.ref022","unstructured":"Colombia, Ministerio de Salud. Gu\u00eda de Pr\u00e1ctica cl\u00ednica: detecci\u00f3n temprana y diagn\u00f3stico del episodio depresivo y trastorno depresivo recurrente en adultos: atenci\u00f3n integral de los adultos con diagn\u00f3stico de episodio depresivo o trastorno depresivo recurrente. c2013 [cited 2017 June 30; Internet]. http:\/\/gpc.minsalud.gov.co\/gpc_sites\/Repositorio\/Conv_500\/GPC_td\/gpc_td.aspx. Spanish."},{"key":"pone.0231700.ref023","volume-title":"Depression in adults: recognition and management","author":"National Institute for Health and Care Excellence","year":"2009"},{"key":"pone.0231700.ref024","volume-title":"Adult depression in primary care","author":"M Trangle"},{"issue":"9","key":"pone.0231700.ref025","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016: clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological Treatments","volume":"61","author":"SH Kennedy","year":"2016","journal-title":"Can J Psychiatry"},{"key":"pone.0231700.ref026","volume-title":"Practice guideline for the treatment of patients with major depressive disorder","author":"AJ Gelenberg","year":"2010"},{"key":"pone.0231700.ref027","volume-title":"Suicide prevention: a resource for counsellors","author":"World Health Organization","year":"2006"},{"issue":"486","key":"pone.0231700.ref028","first-page":"15","article-title":"Characteristics of effective clinical guidelines for general practice","volume":"53","author":"J S Burgers","year":"2003","journal-title":"Br J Gen Pract"},{"key":"pone.0231700.ref029","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jclinepi.2017.05.006","article-title":"The GRADE Working Group clarifies the construct of certainty of evidence","volume":"87","author":"M Hultcrantz","year":"2017","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"pone.0231700.ref030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/bmjqs.2010.043257","article-title":"Guideline adaptation: an approach to enhance efficiency in guideline development and improve utilisation","volume":"20","author":"B Fervers","year":"2011","journal-title":"BMJ Qual Saf"},{"issue":"9156","key":"pone.0231700.ref031","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(98)07516-3","article-title":"Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer","volume":"353","author":"F Eisinger","year":"1999","journal-title":"Lancet"},{"key":"pone.0231700.ref032","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1748-5908-7-61","article-title":"Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations","volume":"7","author":"S Woolf","year":"2012","journal-title":"Implement Sci"},{"key":"pone.0231700.ref033","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40263-015-0267-6","article-title":"Network meta-analysis and cost-effectiveness analysis of new generation antidepressants","volume":"29","author":"AL Khoo","year":"2015","journal-title":"CNS Drugs"},{"key":"pone.0231700.ref034","volume-title":"Grading of Recommendations Assessment, Development, and Evaluation (GRADE)","author":"GRADE Work Group"},{"key":"pone.0231700.ref035","volume-title":"Cochrane handbook for systematic reviews of interventions Version 5.1.0","author":"JPT Higgins","year":"2011"},{"issue":"12","key":"pone.0231700.ref036","first-page":"CD008851","article-title":"Agomelatine versus other antidepressive agents for major depression","author":"G Guaiana","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0231700.ref037","author":"LA Etten","year":"2017","journal-title":"CANMAT guidelines (2016) for the pharmacological treatment of unipolar depression (Episode #02)"},{"key":"pone.0231700.ref038","unstructured":"Brasil, Minist\u00e9rio da Sa\u00fade, Secretaria de Ci\u00eancia, Tecnologia e Insumos Estrat\u00e9gicos. [Rational use of medicines: selected subject]. Bras\u00edlia: MS, 2012. [Internet] http:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/uso_racional_medicamentos_temas_selecionados.pdf."},{"issue":"2","key":"pone.0231700.ref039","first-page":"86","article-title":"Pharmaceutical Approval Update","volume":"34","author":"MM Goldenberg","year":"2009","journal-title":"PT"},{"key":"pone.0231700.ref040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1370\/afm.1687","article-title":"Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis","volume":"13","author":"K Linde","year":"2015","journal-title":"Ann Fam Med"},{"issue":"4","key":"pone.0231700.ref041","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1071\/HC16008","article-title":"Antidepressants for treatment of depression in primary care: a systematic review and meta-analysis","volume":"8","author":"B Arroll","year":"2016","journal-title":"J Prim Health Care"},{"key":"pone.0231700.ref042","first-page":"CD004186","article-title":"Amitriptyline for depression","author":"G Guaiana","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0231700.ref043","article-title":"Tricyclic antidepressant overdose","author":"A Newton","journal-title":"BMJ Best Practice"},{"issue":"11","key":"pone.0231700.ref044","first-page":"3429","article-title":"Use of potentially inappropriate medications by the elderly at home","volume":"21","author":"L Montezano Lopez","year":"2016","journal-title":"Cien Saude Colet"},{"issue":"5","key":"pone.0231700.ref045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2710.2007.00846.x","article-title":"Augmentation strategies for treatment-resistant depression: a literature review","volume":"32","author":"AF Carvalho","year":"2007","journal-title":"J Clin Pharm Ther"},{"issue":"12","key":"pone.0231700.ref046","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","article-title":"Medication augmentation after the failure of SSRIS for depression","volume":"354","author":"MH Trivedi","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"pone.0231700.ref047","first-page":"CD004044","article-title":"Pharmacological treatment for psychotic depression","author":"J Wijkstra","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"pone.0231700.ref048","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.euroneuro.2017.05.007","article-title":"Tranylcypromine in mind (Part I): Review of pharmacology","volume":"27","author":"S Ulrich","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"issue":"8","key":"pone.0231700.ref049","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1176\/appi.ajp.2015.14020181","article-title":"Depression subtypes in predicting antidepressant response: a report from the iSPOT-D Trial","volume":"172","author":"BA Arnow","year":"2015","journal-title":"Am J Psychiatry"},{"issue":"9","key":"pone.0231700.ref050","first-page":"357","article-title":"Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam","volume":"51","author":"PI Rosebush","year":"1990","journal-title":"J Clin Psychiatry"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T20:19:50Z","timestamp":1587500390000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231700"}},"subtitle":[],"editor":[{"given":"Gabriele","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,21]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0231700","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,21]]}}}